Proactive specialist asset management
We provide venture, private equity or debt finance to regional businesses with growth ambition.
Sale of OXGENE
Mercia is pleased to announce the profitable sale of OXGENE.
Dr. Mark Payton speaks about the sale and what it means for the Group.
Meet the Funder
Are you looking to scale your business?
Need that burning investment question answered?
Our virtual ‘Meet the Funder’ event is on every Friday from 9am – Midday, where our Fund Principals, Investment Directors and Business Development Managers will be on hand to talk to you on a range of topics.
All meetings last for 15 minutes and are strictly confidential (2 slots max).
Growing together
What are your ambitions and how can we help you?
We provide regional fast-growth SMEs with the capital crafted to help them scale; flexible funding to meet their immediate needs and the insight, experience and commitment of a team of great people to ensure that everyone invested in this journey grow, together.
In the regions, from the regions, to the regions
Asset management
Our vision is to become the leading manager of regional growth funds and the leading provider of regional capital to ambitious SMEs seeking venture, private equity or debt.
We’ve been looking for you
We don’t back great businesses, we back great people.
We seek to complement you and your team and help build the business around you. We believe people are at the centre of everything we do. Our portfolio has nearly 400 regional businesses; the brightest SMEs inspired to make a difference, great management teams that know what real investment means, traditional businesses that are ready for the next stage of growth and those that need a short-term leg up to reach their full potential.
Sound like you?
Capital solutions
OXGENE™
-
The team
Dr David Hames – Non-exec Chair
Dr Ryan Cawood – CEO
Jocelyne Bath – COO -
Investment
£6.1million since 2013
-
Rationale
Opportunity to be a leading developer, supplier and licensor of a catalogue of synthetic biology technologies (plasmids, cell lines, kits) and products (viral, gene editing, antibody).
Aceleron
-
The team
Clive Scrivener – Chair
Amrit Singh Chandan – CEO
Carlton Cummins – Director -
Investment
£1.2million since 2018
-
Rationale
The company has the potential to disrupt the battery market turning waste components into second-life batteries. Its design for the world’s first serviceable lithium battery offers the opportunity to establish an ‘energy-as-a-service’ business model.
Cobra Sports Exhausts
-
The team
Rachel Abbott – CEO
Michael Jarvis – Director -
Investment
Six figure investment in 2018
-
Rationale
A debt finance deal enabling the company to strengthen its presence in the motorsport market and complete an acquisition.
We are on a global mission to transform how health and safety is managed.
Matthew Elson, CEO
These investments have allowed us to move forward with our plans to increase production capacity, improving efficiency and continue to develop the product range.
Dr Alexander Celik, MD of Rosehill Polymers
The process with Mercia is straightforward and succinct, they have helped with useful introductions, including our new business development director and NED candidates.
Chris Yates, CEO of Abingdon Health
Mercia has proven to be an amazing partner on all fronts, and we are looking forward to greater successes over the coming years as a result of their support.
Ian Wilding, Chair of Locate Bio
#OneMercia Hub
Sign up
We have a range of great webinars, events and news that you won’t want to miss. What better way to stay in touch than signing up for our newsletters.
The Insight
Read Mercia Asset Management PLC’s maiden newsletter, ‘The Insight’ here. Our quarterly newsletter providing a look into its operations and investment activity, with topical commentary from members of the Mercia team.
